Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 7,357 | 6,845 | 8,533 | 5,785 | 0 |
| Gross Profit | 7,357 | 6,845 | 8,533 | 5,785 | N/A |
| Operating Expenses | 18,889 | 17,801 | 20,736 | 16,514 | 19,714 |
| Operating Income | -11,532 | -10,956 | -12,203 | -10,729 | -12,551 |
| Other Income | 1,121 | 1,343 | 1,457 | 1,652 | 1,622 |
| Pre-tax Income | -10,411 | -9,613 | -10,746 | -9,077 | -10,929 |
| Income Tax | -76 | N/A | 406 | N/A | N/A |
| Net Income Continuous | -10,335 | -9,613 | -11,152 | -9,077 | -10,962 |
| Net Income | $-10,335 | $-9,613 | $-11,152 | $-9,077 | $-10,962 |
| EPS Basic Total Ops | -1.54 | -1.51 | -1.98 | -1.66 | -1.75 |
| EPS Basic Continuous Ops | -1.55 | -1.51 | -1.98 | -1.66 | -1.75 |
| EPS Diluted Total Ops | -1.54 | -1.51 | -1.98 | -1.66 | -1.75 |
| EPS Diluted Continuous Ops | -1.55 | -1.51 | -1.98 | -1.66 | -1.75 |
| EPS Diluted Before Non-Recurring Items | -1.57 | -1.51 | -1.98 | N/A | N/A |
| EBITDA(a) | $-12,093 | $-11,764 | $-13,131 | $-11,961 | $-20,681 |